Strategic UK Market Access

Driving a successful UK market access strategy

We understand your objectives and challenges to deliver results:

  • Accelerate adoption – we perfect your early engagement strategy to ensure system readiness and clinical advocacy
  • Optimise reimbursement – we ensure the value of your product is truly understood
  • Establish brand equity and reputation – we support you to build compliant, valued partnerships with NHS customers
  • Earlier recognition of value by key opinion leaders – we give you the knowledge to engage the right people, at the right time, with the right messages
  • Improved field team effectiveness – we provide the tools and training required for success
  • Optimised spread – we help you to drive the sharing of learnings and best practice across the healthcare system

“I was impressed by the calibre of the Associates in your network. It means that we had the perfect experts to provide input on our UK market access strategy. The advisory board was well structured and engaging – 5/5 for facilitation! We have already made a start on the recommendations, and these have really helped us prioritise the different activities and shaped our thinking.”

Pricing, Reimbursement & Access ManagerTop 20 Pharma Company

“Thank you Mtech Access for organising such a collaborative and interesting event, in the Cancer Alliances Above Brand event. Following the workshop sessions, I am really interested in continuing our engagement with the Cancer Alliances.”

Healthcare Account ManagerAmazon Web Services

“The UK Diagnostic Landscape Study has proved to be really good value for money – we’re really pleased. The report has provided our UK team with a lot more detail than we had before, and we are taking learnings forward to apply to our European strategy.”

Market Access and HEOR DirectorDiagnostics and Medical Device company

“Mtech Access is the best consultancy, in my opinion, due to the calibre of the people. The team were really easy to work with, were quick to action everything, and kept us updated on the whole process”

Senior Market Access and Reimbursement ManagerMedtech Company

“The NHS update training session was pitched right so as to resonate with both our market access and clinical teams. We were really interested to find out about the new procurement processes that are being introduced in the NHS and the new Integrated Care System (ICS) structure. The team have already begun leveraging what we learned during the session to approach the right stakeholders with messages focused on quality of life impact.”

UK Head of Market AccessWound Care Company

“I was really pleased with how the advisory board went. The outcomes were good and useful. If you are looking for something slightly different, go to Mtech. [When working with Mtech, ] we know we’re going to get what’s promised and that there will always be delegates with interesting roles who have a real desire to engage in the process.”

Market Access ManagerTop 20 pharma company

"Mtech Access are spot on with their real NHS knowledge and it is always up to date. They are always able to align what’s going on within the NHS with our commercial objectives."

Market Access DirectorPharma

"What Mtech Access do is unique. They have a set of people with varied and experienced roles who can translate between the NHS and industry and offer industry real time feedback.”

Market Access ManagerTop 20 Pharma company

“We have definitely seen benefits from the NHS update sessions. Whilst my team have a strong understanding of the NHS, we want to stay on top of what’s happening. These sessions are useful because we can test our ideas. The insights gained have helped us build value propositions which are well received and accepted.”

Commercial Director Top 20 Medical Devices company

“The mock meeting was excellent and very well delivered. The team were so responsive, easy to communicate with, very flexible and able to implement things last minute. We would definitely do this again with Mtech!”

HTA & Access Leadtop 20 pharma company

To discuss your UK market access strategy with our experts or to learn more about our NHS education and insights services, get in touch using the form below.

    Keep me up to date with the latest news and events.

    Key steps for UK launch and NHS engagement

    We will work with you at system level to evaluate how your new innovations will impact pathways and address unmet needs. This will enable you to effectively communicate the value of your product to key decision-makers and clinicians.

    UK market landscaping and access

    Landscape analysis +

    Understand and evaluate possible access routes, pricing and reimbursement pathways, current models of care, and critical decision-making factors in relation to national and local priorities.

    Competitor analysis +

    Evaluate current and predicted future treatment landscapes.

    Health technology assessment +

    Critique and/or develop all elements of your strategy and submission.

    Shaping and influencing the NHS

    Pathway redesign +

    Truly understand how your product will impact care delivery, the value it could offer, and the challenges it may encounter in the context of care settings, procedures, and clinical staff.

    Funding flows +

    Understand how your product will be/is funded, and the associated implications and opportunities.

    Business case and case for change +

    Support clinical stakeholders to succinctly communicate why transformation is needed, the proposed solution, and the supporting evidence to drive change.

    Data dashboards and models +

    Empower field teams with data dashboards and economic models that illustrate the need for change and model the effect of making a change.

    Stakeholder mapping +

    Understand the NHS customers that you need to engage with, when and how, and their priorities, needs, areas of influence, and challenges.

    NHS engagement materials for field teams +

    Set up field teams for success with dynamic materials that engage NHS customers and drive conversations with key stakeholders.

    UK Market Access flyer - download

    Are you ready to drive change in UK healthcare? Discover how we can support your UK market access strategy

    Download Brochure

    Stay one step ahead on your market access journey

    We use our expertise and curiosity to enable you to stay ahead of the evolving NHS environment to give you the competitive edge. We will work with you to identify, evaluate, and overcome barriers standing between your product and widespread market access, by answering key questions, such as:

    • What data can be leveraged at launch to influence reimbursement and market access?
    • How do we navigate communications and show value at Integrated Care System (ICS), Place, and Primary Care Network (PCN) levels?
    • Who should we talk to across the NHS and what should we be communicating?
    • Where does our product fit within current care pathways; what does it support, replace, or require when being introduced?
    • What lessons can be learnt from competitor(s) and/or analogue launches?
    • What are the real-time and future threats and opportunities for our product(s)?
    • How do we get the attention of key Health Care Professionals (HCPs); should we adopt an above-brand or product-specific strategy from the beginning?
    • How can we creatively and most effectively communicate the holistic value of our product(s) in ways that will really resonate?
    • What are NHS objectives and challenges that you need to align your messaging to, which will enable mutually beneficial outcomes?

    NHS and UK market access articles

    Maximising NHS impact on a budget

    Maximising NHS impact on a budget: assessing value in healthcare

    In this live lecture, Hannah Baker (Consultant – Health Economics) outlines the role health economics plays in modern healthcare…

    So, what is happening with specialised commissioning in the NHS? cover

    So, what is happening with specialised commissioning in the NHS?

    Specialised Commissioning continues to be an issue of significance and uncertainty for both industry and the NHS. What do the latest reports of regional push back on the plans for devolution to ICBs mean?…

    How the life sciences industry can bring meaningful change to the NHS cover

    How the life sciences industry can bring meaningful change to the NHS

    How can the life sciences industry and the NHS work together to deliver real change? An overview of the key themes from our 2023 NHS Transformation Symposium…